CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN SYSTEMIC AMYLOIDOSIS: A SINGLE-CENTER EXPERIENCE

Ümmügülsüm KESKİN, Huseyin DÖNGELLİ, Cihan HEYBELİ, Sulen SARIOĞLU, Mustafa Oktay TARHAN

Journal of Basic and Clinical Health Sciences - 2026;10(2):205-212

Dokuz Eylul University, Department of Internal Medicine, Izmir, Türkiye

 

Purpose: Systemic amyloidosis encompasses a spectrum of protein misfolding disorders that result in amyloid deposition and organ dysfunction. Amyloid A (AA) amyloidosis, typically secondary to chronic inflammatory diseases, remains an important cause of renal morbidity. Therefore, the aim of this study was to evaluate factors associated with renal replacement therapy and mortality in patients with systemic amyloidosis. Materials and Methods: This retrospective single-center cohort study included 79 patients with biopsy-proven systemic amyloidosis diagnosed between 2010 and 2016. Demographic, clinical, and laboratory data were analyzed to identify factors associated with renal replacement therapy (RRT) and overall survival. Amyloid subtypes were determined by histopathology and immunohistochemistry. Results: Of the 79 patients, 62 (78.5%) had AA amyloidosis and 17 (21.5%) other types. The mean age was 55.8 +/- 15.8 years, and 53.2% were female. The median observation duration was 36 months. The kidneys were the most frequently involved organ (75.6%), and nephrotic syndrome was present in 50%. RRT was required in 33.8%, and overall mortality was 43%. Patients with AA amyloidosis were younger (p=0.047) and had higher creatinine and inflammatory markers (p<0.05). In multivariate Cox analysis, baseline serum creatinine (HR=1.20, 95% CI 1.11-1.30, p<0.001) and proteinuria (HR=1.10, 95% CI 1.01-1.20, p=0.031) were independently associated with RRT requirement. Older age was independently associated with mortality, with a 5% increase in risk per year of age (HR=1.05, 95% CI 1.01-1.09, p=0.006). Conclusion: In this cohort of systemic amyloidosis, where AA amyloidosis predominated, renal involvement was frequent and emerged as a major determinant of clinical outcomes. Baseline renal function and proteinuria are key associated factors of progression to RRT, while age remains the main determinant of overall survival.